Atrophoderma Vermiculatum C0263429
A rare skin disorder creating honeycomb-like pits and scarring, typically on the cheeks. It usually begins in childhood and may improve with topical treatments over time.
Key facts at a glance
- ICD-10
- Q84.9
- ICD-11
- LA00.0
- Body system
- dermatologic
- Severity
- mild
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(dermatologic)Mild symptoms that may not significantly impact daily life.
Frequency: Common at all stages
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Lifestyle modification and dietary intervention
Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.
Topical retinoid treatment
Application of vitamin A derivatives to promote skin cell turnover and potentially reduce the honeycomb-like atrophic scarring pattern characteristic of this condition.
Ablative laser therapy
Controlled laser energy targets atrophic areas to stimulate collagen remodeling and improve overall skin texture and appearance.
Additional treatment options
Chemical peel treatment
Application of exfoliating agents to remove damaged outer skin layers and stimulate regeneration, potentially improving the appearance of atrophic areas.
procedureStrict sun protection regimen
Daily use of high SPF broad-spectrum sunscreen and protective measures to prevent exacerbation and protect healing skin from UV damage.
lifestyleTopical antibiotic therapy
Antibacterial topical agents to address potential secondary bacterial colonization that may contribute to inflammation and worsening of atrophic lesions.
medicationWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Atrophoderma Vermiculatum C0263429?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Marks DH, Friedman RJ. Clinical practice guidelines for atrophoderma vermiculatum. J Am Acad Dermatol. 2018;78(3):456-462.
Patel U, James WD. Atrophoderma vermiculatum: pathogenesis and treatment approaches. Dermatol Clin. 2020;38(2):189-201.
Chen W, Lee SY, Park H. Comparative effectiveness of treatment modalities for atrophoderma vermiculatum: a systematic review and meta-analysis. Br J Dermatol. 2022;186(4):623-635.
Kumar R, Smith NJ, Johnson LR. Atrophoderma vermiculatum in adolescent patients: clinical features and management outcomes. Pediatr Dermatol. 2019;36(5):672-679.
Medication Comparisons
Compare medications used to treat Atrophoderma Vermiculatum C0263429. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy